<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Leflunomide</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Leflunomide">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Leflunomide</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Leflunomide</b> (original brand name <b>Arava</b>) is an immunosuppressive disease-modifying antirheumatic drug (DMARD),<span class="mw-ref" id="cite_ref-pmid15271770_2-0"><a href="#cite_note-pmid15271770-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> used in active moderate-to-severe rheumatoid arthritis and psoriatic arthritis. It is a pyrimidine synthesis inhibitor that works by inhibiting dihydroorotate dehydrogenase.<span class="mw-ref" id="cite_ref-pmid17094333_3-0"><a href="#cite_note-pmid17094333-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Arava20mg.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Arava20mg.jpg" data-file-width="640" data-file-height="480" data-file-type="bitmap" height="165" width="220"><div class="thumbcaption" style="text-align: left">Bottle of Leflunomide (Arava) and tablet</div></div></div>

<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Leflunomide</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Leflunomide.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Leflunomide.svg.png" data-file-width="512" data-file-height="324" data-file-type="drawing" height="139" width="220"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline class="mw-default-size"><img src="../I/m/Leflunomide_ball-and-stick_model.png" tppabs="https://ptable.com/wiki/compounds/I/m/Leflunomide_ball-and-stick_model.png" data-file-width="1767" data-file-height="1180" data-file-type="bitmap" height="147" width="220"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Arava, Lefumide, Arabloc, Lunava, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/leflunomide.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/leflunomide.html'" tppabs="https://www.drugs.com/monograph/leflunomide.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a600032.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a600032.html'" tppabs="https://medlineplus.gov/druginfo/meds/a600032.html" class="external text external">a600032</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Leflunomide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Leflunomide'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Leflunomide" class="external text external">by INN</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Leflunomide&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Leflunomide&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Leflunomide&SearchType=BasicSearch" class="external text external">Leflunomide</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>X (High risk)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>X (Contraindicated)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth (tablets)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>L04AA13<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=L04AA13  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=L04AA13'" tppabs="https://www.whocc.no/atc_ddd_index/?code=L04AA13" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">CA</abbr></small>:<span> </span> ℞-only<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>80%<span class="mw-ref" id="cite_ref-MSR_1-0"><a href="#cite_note-MSR-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>&gt;99%<span class="mw-ref" id="cite_ref-MSR_1-1"><a href="#cite_note-MSR-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>GI mucosa and liver<span class="mw-ref" id="cite_ref-MSR_1-2"><a href="#cite_note-MSR-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>14–18 days<span class="mw-ref" id="cite_ref-MSR_1-3"><a href="#cite_note-MSR-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Faeces (48%), urine (43%)<span class="mw-ref" id="cite_ref-MSR_1-4"><a href="#cite_note-MSR-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">5-methyl-<i>N</i>-[4-(trifluoromethyl) phenyl]-isoxazole-4-carboxamide</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=75706-12-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=75706-12-6'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=75706-12-6" class="external text external">75706-12-6</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/3899  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/3899'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/3899" class="external text external">3899</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6825  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6825'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6825" class="external text external">6825</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01097  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01097'" tppabs="https://www.drugbank.ca/drugs/DB01097" class="external text external">DB01097</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.3762.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.3762.html'" tppabs="http://www.chemspider.com/Chemical-Structure.3762.html" class="external text external">3762</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=G162GK9U4W  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=G162GK9U4W'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=G162GK9U4W" class="external text external">G162GK9U4W</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D00749  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D00749'" tppabs="https://www.kegg.jp/entry/D00749" class="external text external">D00749</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6402  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6402'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6402" class="external text external">CHEBI:6402</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL960  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL960'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL960" class="external text external">ChEMBL960</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID9023201  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID9023201'" tppabs="https://comptox.epa.gov/dashboard/DTXSID9023201" class="external text external">DTXSID9023201</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.123.883  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.123.883'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.123.883" class="external text external">100.123.883</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>12</sub><span>H</span><sub>9</sub><span>F</span><sub>3</sub><span>N</span><sub>2</sub><span>O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">270.211</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28Nc1ccc%28cc1%29C%28F%29%28F%29F%29c2c%28onc2%29C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28Nc1ccc%28cc1%29C%28F%29%28F%29F%29c2c%28onc2%29C'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28Nc1ccc%28cc1%29C%28F%29%28F%29F%29c2c%28onc2%29C" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(Nc1ccc(cc1)C(F)(F)F)c2c(onc2)C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18)<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:VHOGYURTWQBHIL-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462089809&page2=Leflunomide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462089809&page2=Leflunomide'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462089809&page2=Leflunomide" class="external text external">(verify)</a></span></span></td></tr></tbody></table>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_use">Medical use</h2></summary>
    
<p>Rheumatoid arthritis and psoriatic arthritis are the only indications that have received regulatory approval.<span class="mw-ref" id="cite_ref-MSR_1-5"><a href="#cite_note-MSR-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-AMH_4-0"><a href="#cite_note-AMH-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Arava was developed by Sanofi Aventis and approved by the U.S. Food and Drug Administration in 1998. Clinical studies regarding the following diseases have been conducted:<span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p> 

<div class="div-col columns column-width" style="-moz-column-width: 22em; -webkit-column-width: 22em; column-width: 22em;   ">
<ul><li>Polyoma BK virus nephropathy<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></li>
<li>Kimura's disease<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></li>
<li>Systemic lupus erythematosus<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></li>
<li>Felty's syndrome<span class="mw-ref" id="cite_ref-pmid12003373_9-0"><a href="#cite_note-pmid12003373-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></li>
<li>Takayasu arteritis<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></li>
<li>Granulomatosis with polyangiitis<span class="mw-ref" id="cite_ref-pmid12003373_9-1"><a href="#cite_note-pmid12003373-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></li>
<li>Ankylosing spondylitis<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></li>
<li>Crohn's disease<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></li>
<li>Sarcoidosis<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></li>
<li>Uveitis<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></li>
<li>Still's disease<span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></li>
<li>Prostate cancer<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></li>
<li>Pemphigoid<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></li>
<li>Prevention of organ transplant rejection<span class="mw-ref" id="cite_ref-rh2010_19-0"><a href="#cite_note-rh2010-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></li></ul>
</div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<p>The dose-limiting side effects are liver damage, lung disease and immunosuppression.<span class="mw-ref" id="cite_ref-rh2010_19-1"><a href="#cite_note-rh2010-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> The most common side effects (occurring in &gt;1% of those treated with it) are, in approximately descending order of frequency:<span class="mw-ref" id="cite_ref-MSR_1-6"><a href="#cite_note-MSR-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-AMH_4-1"><a href="#cite_note-AMH-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-TGA_20-0"><a href="#cite_note-TGA-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-EMA_21-0"><a href="#cite_note-EMA-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span><span class="mw-ref" id="cite_ref-MS_22-0"><a href="#cite_note-MS-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-DM_23-0"><a href="#cite_note-DM-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-EMC_24-0"><a href="#cite_note-EMC-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> diarrhea, respiratory tract infections, hair loss, high blood pressure, rash, nausea, bronchitis, headache, abdominal pain, abnormal liver function tests, back pain, indigestion, urinary tract infection, dizziness, infection, joint disorder, itchiness, weight loss, loss of appetite, cough, gastroenteritis, pharyngitis, stomatitis, tenosynovitis, vomiting, weakness, allergic reaction, chest pain, dry skin, eczema, paraesthesia, pneumonia, rhinitis, synovitis, cholelithiasis and shortness of breath. Whereas uncommon side effects (occurring in 0.1-1% of those treated with the drug) include:<span class="mw-ref" id="cite_ref-AMH_4-2"><a href="#cite_note-AMH-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> constipation, oral thrush, stomatitis, taste disturbance, thrombocytopenia and hives. Rarely (in 0.1% of those treated with it) it can cause:<span class="mw-ref" id="cite_ref-AMH_4-3"><a href="#cite_note-AMH-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> anaphylaxis, angiooedema, anaemia, agranulocytosis, eosinophilia, leucopenia, pancytopenia, vasculitis, toxic epidermal necrolysis, Stevens–Johnson syndrome, cutaneous lupus erythematosus, severe infection, interstitial lung disease, cirrhosis and liver failure.</p>

<p>Though not reported elsewhere, 80 cases of interstitial pneumonitis involving leflunomide have been reported in Japan between 2003 and 2006. One such case resulting in a death was reported in a 2006 article from Japan and the authors suggest a "an inter-racial difference" for the interstitial pneumonitis.<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Contraindications">Contraindications</h3></summary>
    
<p>Contraindications include:<span class="mw-ref" id="cite_ref-MSR_1-7"><a href="#cite_note-MSR-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>
<div class="div-col columns column-width" style="-moz-column-width: 22em; -webkit-column-width: 22em; column-width: 22em;   ">
<ul><li>Pregnancy, women of childbearing potential (unless contraception used)</li>
<li>Liver disease, hepatitis B/C seropositive</li>
<li>Active serious infections</li>
<li>Hypersensitivity</li></ul>
</div>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Interactions">Interactions</h3></summary>
    
<p>Other immunomodulatory treatments should be avoided due to the potential for additive immunosuppressant effects, or in the case of immunostimulants like echinacea or astragalus, reduced therapeutic effects.<span class="mw-ref" id="cite_ref-MSR_1-8"><a href="#cite_note-MSR-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Likewise live vaccines (like haemophilus influenzae type b vaccine and yellow fever vaccines) should be avoided due to the potential for severe infection due to the immunosuppressive nature of the treatment.<span class="mw-ref" id="cite_ref-MSR_1-9"><a href="#cite_note-MSR-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>

<p>The concomitant use of <a href="Methotrexate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methotrexate" title="Methotrexate">methotrexate</a>, in particular, may lead to severe or even fatal liver-damage or hepatotoxicity. Seventy-five percent of all cases of severe liver damage reported until early 2001 were seen under combined drug therapy leflunomide plus methotrexate.<span class="mw-ref" id="cite_ref-Lee_26-0"><a href="#cite_note-Lee-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> However, some studies have shown that the combination of methotrexate and leflunomide in patients with rheumatoid arthritis gave better results than either drug alone.<span class="mw-ref" id="cite_ref-Lee_26-1"><a href="#cite_note-Lee-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    
<p>Leflunomide is an immunomodulatory drug that achieves its effects by inhibiting the mitochondrial enzyme dihydroorotate dehydrogenase (DHODH), which plays a key role in the <i>de novo</i> synthesis of <a href="Uridine_monophosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Uridine_monophosphate" title="Uridine monophosphate">uridine monophosphate</a> (rUMP), which is required for the synthesis of DNA and RNA. Hence, leflunomide inhibits the reproduction of rapidly dividing cells, especially lymphocytes.<span class="mw-ref" id="cite_ref-rh2010_19-2"><a href="#cite_note-rh2010-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>

<p>The inhibition of human DHODH by teriflunomide, the active metabolite of leflunomide, occurs at levels (approximately 600 nM) that are achieved during treatment of rheumatoid arthritis (RA).<span class="mw-ref" id="cite_ref-mech99_27-0"><a href="#cite_note-mech99-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> Teriflunomide also inhibits several tyrosine kinases.<span class="mw-ref" id="cite_ref-rh2010_19-3"><a href="#cite_note-rh2010-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> Teriflunomide prevents the expansion of activated and autoimmune lymphocytes by interfering with their cell cycle progression while nonlymphoid cells are able to use another pathway to make their ribonucleotides by use of salvage pyrimidine pathway, which makes them less dependent on <i>de novo</i> synthesis.<span class="mw-ref" id="cite_ref-mech99_27-1"><a href="#cite_note-mech99-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> Teriflunomide also has antiviral effects against numerous viruses including CMV, HSV1 and the BK virus, which it achieves by inhibiting viral replication by interfering with nucleocapsid tegumentation and hence virion assembly.<span class="mw-ref" id="cite_ref-rh2010_19-4"><a href="#cite_note-rh2010-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacokinetics">Pharmacokinetics</h2></summary>
    
<p>It has an oral bioavailability of 80%, protein binding of &gt;99%, metabolism sites of the GI mucosa and liver, volume of distribution (V<sub>d</sub>) of 0.13 L/kg, elimination half-life of 14–18 days and excretion routes of faeces (48%) and urine (43%).<span class="mw-ref" id="cite_ref-MSR_1-10"><a href="#cite_note-MSR-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-rh2010_19-5"><a href="#cite_note-rh2010-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-TGA_20-1"><a href="#cite_note-TGA-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Leflunomide_metabolism">Leflunomide metabolism</h2></summary>
    
<p>Teriflunomide is the main active <i>in vivo</i> metabolite of leflunomide. Upon administration of leflunomide, 70% of the drug administered converts into teriflunomide. The only difference between the molecules is the opening of the <a href="Isoxazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Isoxazole" title="Isoxazole">isoxazole</a> ring. Upon oral administration of leflunomide <i>in vivo</i>, the isoxazole ring of leflunomide is opened and teriflunomide is formed.<span class="mw-ref" id="cite_ref-Melchiorri_28-0"><a href="#cite_note-Melchiorri-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></p>
<center><div class="thumb tnone"></div><div class="thumbinner" style="width:427px"><img src="../I/m/Activation_of_leflunomide.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Activation_of_leflunomide.svg.png" data-file-width="512" data-file-height="326" data-file-type="drawing" height="271" width="425"><div class="thumbcaption" style="text-align: left"><b>Teriflunomide</b> is the active metabolite of leflunomide, responsible for its therapeutic actions. It results from the reaction of isoxazole ring opening, which occurs <i>in vivo</i>. Teriflunomide then can interconvert between the <i>E</i> and <i>Z</i> enolic forms (and the corresponding keto-amide), with the <i>Z</i>-enol being the most stable and therefore most predominant form.<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></div></div></center>

<p>"Regardless of the substance administered (leflunomide or teriflunomide), it is the same molecule (teriflunomide)—the one exerting the pharmacological, immunological or metabolic action in view of restoring, correcting or modifying physiological functions, and does not present, in clinical use, a new chemical entity to patients."<span class="mw-ref" id="cite_ref-Melchiorri_28-1"><a href="#cite_note-Melchiorri-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> Because of this, the European Medicines Agency (EMA) initially had not considered teriflunomide to be a new active substance.<span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-MSR-1"> <span id="mw-reference-text-cite_note-MSR-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://reference.medscape.com/drug/arava-leflunomide-343203  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://reference.medscape.com/drug/arava-leflunomide-343203#showall'" tppabs="http://reference.medscape.com/drug/arava-leflunomide-343203#showall" class="external text external">"Arava (leflunomide) dosing, indications, interactions, adverse effects, and more"</a>. <i>Medscape Reference</i>. WebMD<span class="reference-accessdate">. Retrieved <span class="nowrap">11 March</span> 2014</span>.</cite></span></li><li id="cite_note-pmid15271770-2"> <span id="mw-reference-text-cite_note-pmid15271770-2" class="mw-reference-text"><cite id="CITEREFDougadosEmeryLemmelZerbini2005" class="citation journal cs1">Dougados M, Emery P, Lemmel EM, Zerbini CA, Brin S, van Riel P (January 2005). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1755199  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1755199'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1755199" class="external text external">"When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?"</a>. <i>Annals of the Rheumatic Diseases</i>. <b>64</b> (1): 44–51. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fard.2003.016709  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fard.2003.016709'" tppabs="https://doi.org/10.1136%2Fard.2003.016709" class="external text external">10.1136/ard.2003.016709</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1755199  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1755199'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1755199" class="external text external">1755199</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15271770  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15271770'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15271770" class="external text external">15271770</a>.</cite></span></li><li id="cite_note-pmid17094333-3"> <span id="mw-reference-text-cite_note-pmid17094333-3" class="mw-reference-text"><cite id="CITEREFPintoDougados2006" class="citation journal cs1">Pinto P, Dougados M (2006). <a href="javascript:if(confirm('https://web.archive.org/web/20090226071252/http://www.spreumatologia.pt/download_fich.php?path=pdfs&filename=ARP_2006_4_216_AR_-_Leflunomide.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090226071252/http://www.spreumatologia.pt/download_fich.php?path=pdfs&filename=ARP_2006_4_216_AR_-_Leflunomide.pdf'" tppabs="https://web.archive.org/web/20090226071252/http://www.spreumatologia.pt/download_fich.php?path=pdfs&filename=ARP_2006_4_216_AR_-_Leflunomide.pdf" class="external text external">"Leflunomide in clinical practice"</a> <span class="cs1-format">(PDF)</span>. <i>Acta Reumatológica Portuguesa</i>. <b>31</b> (3): 215–24. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17094333  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17094333'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17094333" class="external text external">17094333</a>. Archived from <a href="javascript:if(confirm('http://www.spreumatologia.pt/download_fich.php?path=pdfs&filename=ARP_2006_4_216_AR_-_Leflunomide.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.spreumatologia.pt/download_fich.php?path=pdfs&filename=ARP_2006_4_216_AR_-_Leflunomide.pdf'" tppabs="http://www.spreumatologia.pt/download_fich.php?path=pdfs&filename=ARP_2006_4_216_AR_-_Leflunomide.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 2009-02-26<span class="reference-accessdate">. Retrieved <span class="nowrap">2008-11-01</span></span>.</cite></span></li><li id="cite_note-AMH-4"> <span id="mw-reference-text-cite_note-AMH-4" class="mw-reference-text"><cite id="CITEREFRossi,_S2013" class="citation book cs1">Rossi, S, ed. (2013). <i>Australian Medicines Handbook</i> (2013 ed.). Adelaide: The Australian Medicines Handbook Unit Trust. ISBN<span>&nbsp;</span><bdi>978-0-9805790-9-3</bdi>.</cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><a href="javascript:if(confirm('http://clinicaltrials.gov/ct2/results?term=Leflunomide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://clinicaltrials.gov/ct2/results?term=Leflunomide'" tppabs="http://clinicaltrials.gov/ct2/results?term=Leflunomide" class="external free external">http://clinicaltrials.gov/ct2/results?term=Leflunomide</a></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFBlanckaertDe_Vriese,_AS2006" class="citation journal cs1">Blanckaert, K; De Vriese, AS (23 September 2006). <a href="javascript:if(confirm('http://ndt.oxfordjournals.org/content/21/12/3364.full.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://ndt.oxfordjournals.org/content/21/12/3364.full.pdf'" tppabs="http://ndt.oxfordjournals.org/content/21/12/3364.full.pdf" class="external text external">"Current recommendations for diagnosis and management of polyoma BK virus nephropathy in renal transplant recipients"</a> <span class="cs1-format">(PDF)</span>. <i>Nephrology Dialysis Transplantation</i>. <b>21</b> (12): 3364–3367. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Fndt%2Fgfl404  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fndt%2Fgfl404'" tppabs="https://doi.org/10.1093%2Fndt%2Fgfl404" class="external text external">10.1093/ndt/gfl404</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16998219  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16998219'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16998219" class="external text external">16998219</a>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFDaiWei,_XNZheng,_DHMo,_YQ2011" class="citation journal cs1">Dai, L; Wei, XN; Zheng, DH; Mo, YQ; Pessler, F; Zhang, BY (June 2011). "Effective treatment of Kimura's disease with leflunomide in combination with glucocorticoids". <i>Clinical Rheumatology</i>. <b>30</b> (6): 859–65. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs10067-011-1689-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs10067-011-1689-2'" tppabs="https://doi.org/10.1007%2Fs10067-011-1689-2" class="external text external">10.1007/s10067-011-1689-2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21286771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21286771'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21286771" class="external text external">21286771</a>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite id="CITEREFWuXu,_XDHuang,_QWu,_H2013" class="citation journal cs1">Wu, GC; Xu, XD; Huang, Q; Wu, H (February 2013). "Leflunomide: friend or foe for systemic lupus erythematosus?". <i>Rheumatology International</i>. <b>33</b> (2): 273–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00296-012-2508-z  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00296-012-2508-z'" tppabs="https://doi.org/10.1007%2Fs00296-012-2508-z" class="external text external">10.1007/s00296-012-2508-z</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22961090  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22961090'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22961090" class="external text external">22961090</a>.</cite></span></li><li id="cite_note-pmid12003373-9"> <span id="mw-reference-text-cite_note-pmid12003373-9" class="mw-reference-text"><cite id="CITEREFSanders,_SHarisdangkul,_V2002" class="citation journal cs1">Sanders, S; Harisdangkul, V (2002). "Leflunomide for the treatment of rheumatoid arthritis and autoimmunity". <i>American Journal of the Medical Sciences</i>. <b>323</b> (4): 190–3. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00000441-200204000-00004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00000441-200204000-00004'" tppabs="https://doi.org/10.1097%2F00000441-200204000-00004" class="external text external">10.1097/00000441-200204000-00004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12003373  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12003373'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12003373" class="external text external">12003373</a>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFUnizonyStone,_JHStone,_JR2013" class="citation journal cs1">Unizony, S; Stone, JH; Stone, JR (January 2013). <a href="javascript:if(confirm('http://www.medscape.com/viewarticle/776095  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medscape.com/viewarticle/776095'" tppabs="http://www.medscape.com/viewarticle/776095" class="external text external">"New treatment strategies in large-vessel vasculitis"</a>. <i>Current Opinion in Rheumatology</i>. <b>25</b> (1): 3–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2FBOR.0b013e32835b133a  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2FBOR.0b013e32835b133a'" tppabs="https://doi.org/10.1097%2FBOR.0b013e32835b133a" class="external text external">10.1097/BOR.0b013e32835b133a</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23114585  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23114585'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23114585" class="external text external">23114585</a>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFHaibelRudwaleit,_MBraun,_JSieper,_J2005" class="citation journal cs1">Haibel, H; Rudwaleit, M; Braun, J; Sieper, J (January 2005). <a href="javascript:if(confirm('http://ard.bmj.com/content/64/1/124.full.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://ard.bmj.com/content/64/1/124.full.pdf'" tppabs="http://ard.bmj.com/content/64/1/124.full.pdf" class="external text external">"Six months open label trial of leflunomide in active ankylosing spondylitis"</a> <span class="cs1-format">(PDF)</span>. <i>Annals of the Rheumatic Diseases</i>. <b>64</b> (1): 124–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fard.2003.019174  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fard.2003.019174'" tppabs="https://doi.org/10.1136%2Fard.2003.019174" class="external text external">10.1136/ard.2003.019174</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1755172  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1755172'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1755172" class="external text external">1755172</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15608310  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15608310'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15608310" class="external text external">15608310</a>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite id="CITEREFPrajapatiKnox,_JFEmmons,_JSaeian,_K2003" class="citation journal cs1">Prajapati, DN; Knox, JF; Emmons, J; Saeian, K; Csuka, ME; Binion, DG (August 2003). "Leflunomide treatment of Crohn's disease patients intolerant to standard immunomodulator therapy". <i>Journal of Clinical Gastroenterology</i>. <b>37</b> (2): 125–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F00004836-200308000-00006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F00004836-200308000-00006'" tppabs="https://doi.org/10.1097%2F00004836-200308000-00006" class="external text external">10.1097/00004836-200308000-00006</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12869881  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12869881'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12869881" class="external text external">12869881</a>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFHoltmannGerts,_ALWeinman,_AGalle,_PR2008" class="citation journal cs1">Holtmann, MH; Gerts, AL; Weinman, A; Galle, PR; Neurath, MF (April 2008). "Treatment of Crohn's disease with leflunomide as second-line immunosuppression<span>&nbsp;</span>: a phase 1 open-label trial on efficacy, tolerability and safety". <i>Digestive Diseases and Sciences</i>. <b>53</b> (4): 1025–32. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs10620-007-9953-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs10620-007-9953-7'" tppabs="https://doi.org/10.1007%2Fs10620-007-9953-7" class="external text external">10.1007/s10620-007-9953-7</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17934840  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17934840'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17934840" class="external text external">17934840</a>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite id="CITEREFPanselinasJudson,_MA2012" class="citation journal cs1">Panselinas, E; Judson, MA (October 2012). <a href="javascript:if(confirm('http://journal.publications.chestnet.org/data/Journals/CHEST/25163/chest_142_4_827.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://journal.publications.chestnet.org/data/Journals/CHEST/25163/chest_142_4_827.pdf'" tppabs="http://journal.publications.chestnet.org/data/Journals/CHEST/25163/chest_142_4_827.pdf" class="external text external">"Acute pulmonary exacerbations of sarcoidosis"</a> <span class="cs1-format">(PDF)</span>. <i>Chest</i>. <b>142</b> (4): 827–36. doi:<a href="javascript:if(confirm('https://doi.org/10.1378%2Fchest.12-1060  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1378%2Fchest.12-1060'" tppabs="https://doi.org/10.1378%2Fchest.12-1060" class="external text external">10.1378/chest.12-1060</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23032450  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23032450'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23032450" class="external text external">23032450</a>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFRoy2007" class="citation journal cs1">Roy, M (August 2007). "Early clinical experience with leflunomide in uveitis". <i>Canadian Journal of Ophthalmology</i>. <b>42</b> (4): 634. doi:<a href="javascript:if(confirm('https://doi.org/10.3129%2Fcan.j.ophthalmol.i07-085  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3129%2Fcan.j.ophthalmol.i07-085'" tppabs="https://doi.org/10.3129%2Fcan.j.ophthalmol.i07-085" class="external text external">10.3129/can.j.ophthalmol.i07-085</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17641721  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17641721'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17641721" class="external text external">17641721</a>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFPirildar2003" class="citation journal cs1">Pirildar, T (May 2003). "Treatment of adult-onset Still's disease with leflunomide and chloroquine combination in two patients". <i>Clinical Rheumatology</i>. <b>22</b> (2): 157. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs10067-002-0667-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs10067-002-0667-0'" tppabs="https://doi.org/10.1007%2Fs10067-002-0667-0" class="external text external">10.1007/s10067-002-0667-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12740686  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12740686'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12740686" class="external text external">12740686</a>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://clinicaltrials.gov/ct2/show/NCT00004071  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://clinicaltrials.gov/ct2/show/NCT00004071'" tppabs="http://clinicaltrials.gov/ct2/show/NCT00004071" class="external text external">"Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer"</a>. <i>ClinicalTrials.gov</i>. National Institute of Health. September 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">11 March</span> 2014</span>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://clinicaltrials.gov/ct2/show/NCT00802243  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://clinicaltrials.gov/ct2/show/NCT00802243'" tppabs="http://clinicaltrials.gov/ct2/show/NCT00802243" class="external text external">"Leflunomide Associated With Topical Corticosteroids for Bullous Pemphigoid (ARABUL)"</a>. <i>ClinicalTrials.gov</i>. National Institute of Health. December 2008<span class="reference-accessdate">. Retrieved <span class="nowrap">11 March</span> 2014</span>.</cite></span></li><li id="cite_note-rh2010-19"> <span id="mw-reference-text-cite_note-rh2010-19" class="mw-reference-text"><cite id="CITEREFTeschnerBurst,_V2010" class="citation journal cs1">Teschner, S; Burst, V (September 2010). "Leflunomide: a drug with a potential beyond rheumatology". <i>Immunotherapy</i>. <b>2</b> (5): 637–50. doi:<a href="javascript:if(confirm('https://doi.org/10.2217%2Fimt.10.52  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2217%2Fimt.10.52'" tppabs="https://doi.org/10.2217%2Fimt.10.52" class="external text external">10.2217/imt.10.52</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20874647  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20874647'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20874647" class="external text external">20874647</a>.</cite></span></li><li id="cite_note-TGA-20"> <span id="mw-reference-text-cite_note-TGA-20" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-05926-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-05926-3'" tppabs="https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-05926-3" class="external text external">"PRODUCT INFORMATION ARAVA"</a> <span class="cs1-format">(PDF)</span>. <i>TGA eBusiness Services</i>. sanofi-aventis australia pty ltd. 7 August 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">11 March</span> 2014</span>.</cite></span></li><li id="cite_note-EMA-21"> <span id="mw-reference-text-cite_note-EMA-21" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000235/WC500026289.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000235/WC500026289.pdf'" tppabs="http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000235/WC500026289.pdf" class="external text external">"Arava<span>&nbsp;</span>: EPAR - Product Information"</a> <span class="cs1-format">(PDF)</span>. <i>European Medicines Agency</i>. Sanofi-Aventis Deutschland GmbH. 21 November 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">11 March</span> 2014</span>.</cite></span></li><li id="cite_note-MS-22"> <span id="mw-reference-text-cite_note-MS-22" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.medsafe.govt.nz/profs/datasheet/a/aravatab.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medsafe.govt.nz/profs/datasheet/a/aravatab.pdf'" tppabs="http://www.medsafe.govt.nz/profs/datasheet/a/aravatab.pdf" class="external text external">"Data Sheet Arava"</a> <span class="cs1-format">(PDF)</span>. <i>Medsafe</i>. sanofi-aventis new zealand limited. 29 June 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">11 March</span> 2014</span>.</cite></span></li><li id="cite_note-DM-23"> <span id="mw-reference-text-cite_note-DM-23" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=320f63f2-fac3-4aee-aff8-85724e00ef52  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=320f63f2-fac3-4aee-aff8-85724e00ef52'" tppabs="http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=320f63f2-fac3-4aee-aff8-85724e00ef52" class="external text external">"ARAVA (leflunomide) tablet, film coated <span>[</span>sanofi-aventis U.S. LLC<span>]</span>"</a>. <i>DailyMed</i>. sanofi-aventis U.S. LLC. November 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">11 March</span> 2014</span>.</cite></span></li><li id="cite_note-EMC-24"> <span id="mw-reference-text-cite_note-EMC-24" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.medicines.org.uk/emc/medicine/26343/SPC/Arava+100mg+Tablets/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medicines.org.uk/emc/medicine/26343/SPC/Arava+100mg+Tablets/'" tppabs="http://www.medicines.org.uk/emc/medicine/26343/SPC/Arava+100mg+Tablets/" class="external text external">"Arava 100mg Tablets - Summary of Product Characteristic"</a>. <i>electronic Medicines Compendium</i>. SANOFI. 21 February 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">11 March</span> 2014</span>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFHirabayashi2006" class="citation journal cs1">Hirabayashi, Yu;  et al. (2006). <a href="javascript:if(confirm('https://doi.org/10.2169/internalmedicine.45.1455  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2169/internalmedicine.45.1455'" tppabs="https://doi.org/10.2169/internalmedicine.45.1455" class="external text external">"Leflunomide-Induced Pneumonitis in a Patient with Rheumatoid Arthritis"</a>. <i>Internal Medicine</i>. <b>45</b> (10): 689–691. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.2169%2Finternalmedicine.45.1455  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2169%2Finternalmedicine.45.1455'" tppabs="https://doi.org/10.2169%2Finternalmedicine.45.1455" class="external text external">10.2169/internalmedicine.45.1455</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1349-7235  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1349-7235'" tppabs="https://www.worldcat.org/issn/1349-7235" class="external text external">1349-7235</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16778342  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16778342'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16778342" class="external text external">16778342</a>.</cite></span></li><li id="cite_note-Lee-26"> <span id="mw-reference-text-cite_note-Lee-26" class="mw-reference-text"><cite id="CITEREFLeeParkParkKang2009" class="citation journal cs1">Lee, S.; Park, Y.; Park, J.; Kang, Y.; Nam, E.; Kim, S.; Lee, J.; Yoo, W.; Lee, S. (2009). "Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis". <i>Scandinavian Journal of Rheumatology</i>. <b>38</b> (1): 11–14. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F03009740802360632  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F03009740802360632'" tppabs="https://doi.org/10.1080%2F03009740802360632" class="external text external">10.1080/03009740802360632</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19191187  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19191187'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19191187" class="external text external">19191187</a>.</cite></span></li><li id="cite_note-mech99-27"> <span id="mw-reference-text-cite_note-mech99-27" class="mw-reference-text"><cite id="CITEREFFoxHerrmann,_MLFrangou,_CGWahl,_GM1999" class="citation journal cs1">Fox, RI; Herrmann, ML; Frangou, CG; Wahl, GM; Morris, RE; Strand, V; Kirschbaum, BJ (December 1999). "Mechanism of action for leflunomide in rheumatoid arthritis". <i>Clinical Immunology</i>. <b>93</b> (3): 198–208. doi:<a href="javascript:if(confirm('https://doi.org/10.1006%2Fclim.1999.4777  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1006%2Fclim.1999.4777'" tppabs="https://doi.org/10.1006%2Fclim.1999.4777" class="external text external">10.1006/clim.1999.4777</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10600330  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10600330'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10600330" class="external text external">10600330</a>.</cite></span></li><li id="cite_note-Melchiorri-28"> <span id="mw-reference-text-cite_note-Melchiorri-28" class="mw-reference-text"><cite id="CITEREFMelchiorriBarbaraRomaldasNela" class="citation web cs1">Melchiorri, Daniela; Barbara, van Zwieten-Boot; Romaldas, Maciulaitis; Nela, Vilceanu; Karsten, Bruins Slot; Ian, Hudson; Robert, Hemmings; Harald, Enzmann; Pierre, Demolis. <a href="javascript:if(confirm('http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002514/WC500148684.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002514/WC500148684.pdf'" tppabs="http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002514/WC500148684.pdf" class="external text external">"Assessment report. AUBAGIO (international non-proprietary name: teriflunomide). Procedure No. EMEA/H/C/002514/0000"</a> <span class="cs1-format">(PDF)</span>. <i>European Medicines Agency</i>. European Medicines Agency. p.<span>&nbsp;</span>119<span class="reference-accessdate">. Retrieved <span class="nowrap">5 June</span> 2015</span>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite id="CITEREFRozman2002" class="citation journal cs1">Rozman, B (2002). "Clinical Pharmacokinetics of Leflunomide". <i>Clinical Pharmacokinetics</i>. <b>41</b> (6): 421–30. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003088-200241060-00003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003088-200241060-00003'" tppabs="https://doi.org/10.2165%2F00003088-200241060-00003" class="external text external">10.2165/00003088-200241060-00003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12074690  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12074690'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12074690" class="external text external">12074690</a>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20905_ARAVA_BIOPHARMR.PDF  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20905_ARAVA_BIOPHARMR.PDF'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20905_ARAVA_BIOPHARMR.PDF" class="external text external">"Clinical Pharmacology/Biopharmaceutics Review. Product: ARAVA (leflunomide tablets). Application Number: NDA 20905"</a> <span class="cs1-format">(PDF)</span>. <i>U.S. Food and Drug Administration</i>. Center for Drug Evaluation and Research<span class="reference-accessdate">. Retrieved <span class="nowrap">15 April</span> 2016</span>.</cite></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/002514/WC500144913.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/002514/WC500144913.pdf'" tppabs="http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/002514/WC500144913.pdf" class="external text external">"Summary of Opinion (Initial Authorisation): Aubagio (teriflunomide)"</a> <span class="cs1-format">(PDF)</span>. European Medicines Agency<span class="reference-accessdate">. Retrieved <span class="nowrap">15 April</span> 2016</span>.</cite></span></li></ol></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><a href="javascript:if(confirm('http://www.arava.com/hcp/default.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.arava.com/hcp/default.aspx'" tppabs="http://www.arava.com/hcp/default.aspx" class="external text external">ARAVA (leflunomide) 14 mg tablets</a> — Arava HCP website</li>
<li><a href="javascript:if(confirm('https://web.archive.org/web/20100327090922/http://www.nras.org.uk/about_rheumatoid_arthritis/newly_diagnosed/which_drugs_are_used/dmards_used_in_the_treatment_of_ra.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100327090922/http://www.nras.org.uk/about_rheumatoid_arthritis/newly_diagnosed/which_drugs_are_used/dmards_used_in_the_treatment_of_ra.aspx'" tppabs="https://web.archive.org/web/20100327090922/http://www.nras.org.uk/about_rheumatoid_arthritis/newly_diagnosed/which_drugs_are_used/dmards_used_in_the_treatment_of_ra.aspx" class="external text external">National Rheumatoid Arthritis Society (NRAS)</a> Information about Disease Modifying drugs such as Leflunomide</li>
<li><a href="javascript:if(confirm('http://www.rheuma-online.de/medikamente/leflunomid-arava/studien-zu-leflunomid-arava/gibt-es-untersuchungen-zu-leflunomid-in-weiteren-einsatzgebieten.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rheuma-online.de/medikamente/leflunomid-arava/studien-zu-leflunomid-arava/gibt-es-untersuchungen-zu-leflunomid-in-weiteren-einsatzgebieten.html'" tppabs="http://www.rheuma-online.de/medikamente/leflunomid-arava/studien-zu-leflunomid-arava/gibt-es-untersuchungen-zu-leflunomid-in-weiteren-einsatzgebieten.html" class="external free external">http://www.rheuma-online.de/medikamente/leflunomid-arava/studien-zu-leflunomid-arava/gibt-es-untersuchungen-zu-leflunomid-in-weiteren-einsatzgebieten.html</a> (in German, regarding potential indications)</li>
<li><a href="javascript:if(confirm('http://www.arznei-telegramm.de/register/0204507.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.arznei-telegramm.de/register/0204507.pdf'" tppabs="http://www.arznei-telegramm.de/register/0204507.pdf" class="external free external">http://www.arznei-telegramm.de/register/0204507.pdf</a> (in German, regarding discontinuation of the drug)</li>
<li><a href="javascript:if(confirm('https://web.archive.org/web/20061120230350/http://www.emea.europa.eu/pdfs/human/press/pus/561101en.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20061120230350/http://www.emea.europa.eu/pdfs/human/press/pus/561101en.pdf'" tppabs="https://web.archive.org/web/20061120230350/http://www.emea.europa.eu/pdfs/human/press/pus/561101en.pdf" class="external free external">https://web.archive.org/web/20061120230350/http://www.emea.europa.eu/pdfs/human/press/pus/561101en.pdf</a> (warning as of 2001 regarding hepatotoxicity) (URL DEAD 16 Oct 2010)</li>
<li><a href="javascript:if(confirm('http://www.australianprescriber.com/magazine/36/1/28/32  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.australianprescriber.com/magazine/36/1/28/32'" tppabs="http://www.australianprescriber.com/magazine/36/1/28/32" class="external text external">The safety of leflunomide</a> Australian Prescriber</li></ul>

<div role="navigation" class="navbox" aria-labelledby="Immunosuppressive_drugs_/_Immunosuppressants_(L04)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Immunosuppressive_drugs_/_Immunosuppressants_(L04)" style="font-size:114%;margin:0 4em">Immunosuppressive drugs<span>&nbsp;</span>/ Immunosuppressants (L04)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Intracellular<br>(initiation)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Antimetabolites</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>purine synthesis inhibitors</i>
<ul><li><a href="Azathioprine.htm" tppabs="https://ptable.com/wiki/compounds/A/Azathioprine" title="Azathioprine">Azathioprine</a></li>
<li><a href="Mycophenolic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Mycophenolic_acid" title="Mycophenolic acid">Mycophenolic acid</a></li></ul></li></ul>

<ul><li><i>pyrimidine synthesis inhibitors</i>
<ul><li><a href="Leflunomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Leflunomide" title="Leflunomide">Leflunomide</a></li>
<li>Teriflunomide</li></ul></li></ul>

<ul><li><i>antifolate</i>
<ul><li><a href="Methotrexate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methotrexate" title="Methotrexate">Methotrexate</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Macrolides/<br>other <a href="Interleukin_2.htm" tppabs="https://ptable.com/wiki/compounds/A/Interleukin_2" title="Interleukin 2">IL-2</a> inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>FKBP/Cyclophilin/Calcineurin</i>
<ul><li><a href="Tacrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li>
<li><a href="Ciclosporin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ciclosporin" title="Ciclosporin">Ciclosporin</a></li>
<li><a href="Pimecrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimecrolimus" title="Pimecrolimus">Pimecrolimus</a></li></ul></li></ul>

<ul><li>Abetimus</li>
<li>Gusperimus</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">IMiDs</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Lenalidomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lenalidomide" title="Lenalidomide">Lenalidomide</a></li>
<li>Pomalidomide</li>
<li><a href="Thalidomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Thalidomide" title="Thalidomide">Thalidomide</a></li>
<li><i>PDE4 inhibitor</i>
<ul><li>Apremilast</li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Intracellular<br>(reception)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">IL-1 receptor antagonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Anakinra.htm" tppabs="https://ptable.com/wiki/compounds/A/Anakinra" title="Anakinra">Anakinra</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">mTOR</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Sirolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Sirolimus" title="Sirolimus">Sirolimus</a></li>
<li><a href="Everolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Everolimus" title="Everolimus">Everolimus</a></li>
<li>Ridaforolimus</li>
<li><a href="Temsirolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Temsirolimus" title="Temsirolimus">Temsirolimus</a></li>
<li>Umirolimus</li>
<li>Zotarolimus</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Extracellular</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Antibody.htm" tppabs="https://ptable.com/wiki/compounds/A/Antibody" title="Antibody">Antibodies</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Monoclonal</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Serum target<br>(noncellular)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Complement component 5</i>
<ul><li>Eculizumab</li></ul></li>
<li><i>TNF</i>
<ul><li><a href="Adalimumab.htm" tppabs="https://ptable.com/wiki/compounds/A/Adalimumab" title="Adalimumab">Adalimumab</a></li>
<li>Afelimomab</li>
<li>Certolizumab pegol</li>
<li>Golimumab</li>
<li><a href="Infliximab.htm" tppabs="https://ptable.com/wiki/compounds/A/Infliximab" title="Infliximab">Infliximab</a></li>
<li>Nerelimomab</li></ul></li>
<li><i>Interleukin 5</i>
<ul><li>Mepolizumab</li></ul></li>
<li><i>Immunoglobulin E</i>
<ul><li><a href="Omalizumab.htm" tppabs="https://ptable.com/wiki/compounds/A/Omalizumab" title="Omalizumab">Omalizumab</a></li></ul></li></ul>

<ul><li><i>Interferon</i>
<ul><li>Faralimomab</li></ul></li></ul>

<ul><li><i>IL-6</i>
<ul><li>Elsilimomab</li></ul></li></ul>

<ul><li><i>IL-12 and IL-23</i>
<ul><li>Lebrikizumab</li>
<li>Ustekinumab</li></ul></li></ul>

<ul><li><i>IL-17A</i>
<ul><li>Secukinumab</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Cellular<br>target</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>CD3</i>
<ul><li><a href="Muromonab-CD3.htm" tppabs="https://ptable.com/wiki/compounds/A/Muromonab-CD3" title="Muromonab-CD3">Muromonab-CD3</a></li>
<li>Otelixizumab</li>
<li>Teplizumab</li>
<li>Visilizumab</li></ul></li>
<li><i>CD4</i>
<ul><li>Clenoliximab</li>
<li>Keliximab</li>
<li>Zanolimumab</li></ul></li>
<li><i>CD11a</i>
<ul><li>Efalizumab</li></ul></li>
<li><i>CD18</i>
<ul><li>Erlizumab</li></ul></li>
<li><i>CD20</i>
<ul><li>Obinutuzumab</li>
<li><a href="Rituximab.htm" tppabs="https://ptable.com/wiki/compounds/A/Rituximab" title="Rituximab">Rituximab</a></li>
<li>Ocrelizumab</li>
<li>Pascolizumab</li></ul></li>
<li><i>CD23</i>
<ul><li>Gomiliximab</li>
<li>Lumiliximab</li></ul></li>
<li><i>CD40</i>
<ul><li>Teneliximab</li>
<li>Toralizumab</li></ul></li>
<li><i>CD62L/L-selectin</i>
<ul><li>Aselizumab</li></ul></li>
<li><i>CD80</i>
<ul><li>Galiximab</li></ul></li>
<li><i>CD147/Basigin</i>
<ul><li>Gavilimomab</li></ul></li>
<li><i>CD154</i>
<ul><li>Ruplizumab</li></ul></li></ul>

<ul><li><i>BLyS</i>
<ul><li>Belimumab</li>
<li>Blisibimod</li></ul></li>
<li><i>CTLA-4</i>
<ul><li>Ipilimumab</li>
<li>Tremelimumab</li></ul></li>
<li><i>CAT</i>
<ul><li>Bertilimumab</li>
<li>Lerdelimumab</li>
<li>Metelimumab</li></ul></li>
<li><i>Integrin</i>
<ul><li>Natalizumab</li>
<li>Vedolizumab</li></ul></li>
<li><i>Interleukin-6 receptor</i>
<ul><li>Tocilizumab</li></ul></li>
<li><i>LFA-1</i>
<ul><li>Odulimomab</li></ul></li></ul>

<ul><li><i>IL-2 receptor/CD25</i>
<ul><li><a href="Basiliximab.htm" tppabs="https://ptable.com/wiki/compounds/A/Basiliximab" title="Basiliximab">Basiliximab</a></li>
<li><a href="Daclizumab.htm" tppabs="https://ptable.com/wiki/compounds/A/Daclizumab" title="Daclizumab">Daclizumab</a></li>
<li>Inolimomab</li></ul></li></ul>

<ul><li><i>T-lymphocyte</i> (Zolimomab aritox)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Unsorted</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Atorolimumab</li>
<li>Cedelizumab</li>
<li>Fontolizumab</li>
<li>Maslimomab</li>
<li>Morolimumab</li>
<li>Pexelizumab</li>
<li>Reslizumab</li>
<li>Rovelizumab</li>
<li>Siplizumab</li>
<li>Talizumab</li>
<li>Telimomab aritox</li>
<li>Vapaliximab</li>
<li>Vepalimomab</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Polyclonal</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Anti-thymocyte globulin</li>
<li>Anti-lymphocyte globulin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">-cept (Fusion)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>CTLA-4</i>
<ul><li>Abatacept</li>
<li>Belatacept</li></ul></li>
<li><i>TNF inhibitor</i>
<ul><li><a href="Etanercept.htm" tppabs="https://ptable.com/wiki/compounds/A/Etanercept" title="Etanercept">Etanercept</a></li>
<li>Pegsunercept</li></ul></li>
<li>Aflibercept</li>
<li><a href="Alefacept.htm" tppabs="https://ptable.com/wiki/compounds/A/Alefacept" title="Alefacept">Alefacept</a></li>
<li>Rilonacept</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Specific_antirheumatic_products_/_DMARDs_(M01C)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Specific_antirheumatic_products_/_DMARDs_(M01C)" style="font-size:114%;margin:0 4em">Specific antirheumatic products / DMARDs (M01C)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Quinoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinoline" title="Quinoline">Quinolines</a></th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Oxycinchophen</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Gold preparations</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Sodium aurothiomalate</li>
<li>Sodium aurothiosulfate</li>
<li><a href="Auranofin.htm" tppabs="https://ptable.com/wiki/compounds/A/Auranofin" title="Auranofin">Auranofin</a></li>
<li><a href="Aurothioglucose.htm" tppabs="https://ptable.com/wiki/compounds/A/Aurothioglucose" title="Aurothioglucose">Aurothioglucose</a></li>
<li>Aurotioprol</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Penicillamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Penicillamine" title="Penicillamine">Penicillamine</a> #/Bucillamine</li>
<li><a href="Chloroquine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chloroquine" title="Chloroquine">Chloroquine</a> #/<a href="Hydroxychloroquine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxychloroquine" title="Hydroxychloroquine">Hydroxychloroquine</a></li>
<li><a href="Leflunomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Leflunomide" title="Leflunomide">Leflunomide</a></li>
<li><a href="Sulfasalazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulfasalazine" title="Sulfasalazine">Sulfasalazine</a> #</li>
<li><i>antifolate</i> (<a href="Methotrexate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methotrexate" title="Methotrexate">Methotrexate</a> #)</li>
<li><i>thiopurine</i> (<a href="Azathioprine.htm" tppabs="https://ptable.com/wiki/compounds/A/Azathioprine" title="Azathioprine">Azathioprine</a>) #</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>







<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>